Andrew Cooper
Stock Analyst at Raymond James
(0.36)
# 4,099
Out of 4,382 analysts
202
Total ratings
38.8%
Success rate
-4.7%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Reiterated: Buy | $95 → $101 | $91.98 | +9.81% | 6 | Feb 23, 2026 | |
| GH Guardant Health | Reiterated: Buy | $61 → $129 | $125.61 | +2.70% | 11 | Feb 23, 2026 | |
| MYGN Myriad Genetics | Maintained: Buy | $8 | $4.57 | +75.05% | 9 | Jan 13, 2026 | |
| AZTA Azenta | Reiterated: Buy | $35 → $45 | $22.69 | +98.33% | 4 | Nov 25, 2025 | |
| AVTR Avantor | Downgraded: Hold | n/a | $9.16 | - | 15 | Nov 4, 2025 | |
| RVTY Revvity | Reiterated: Buy | $115 | $98.37 | +16.91% | 8 | Oct 28, 2025 | |
| HAE Haemonetics | Downgraded: Buy | $105 → $78 | $71.28 | +9.43% | 12 | Aug 11, 2025 | |
| QDEL QuidelOrtho | Maintained: Buy | $60 → $55 | $14.33 | +283.81% | 28 | Aug 6, 2025 | |
| FLGT Fulgent Genetics | Reiterated: Buy | $25 | $19.15 | +30.55% | 4 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $525 → $535 | $472.80 | +13.16% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $184.30 | - | 7 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $223.97 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.90 | n/a | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $175 | $215.31 | n/a | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.25 | n/a | 25 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.09 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $48.73 | n/a | 9 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.04 | n/a | 14 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,050 | $0.0001 | n/a | 11 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.00 | n/a | 2 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $562.16 | n/a | 3 | Feb 2, 2021 |
Integer Holdings
Feb 23, 2026
Reiterated: Buy
Price Target: $95 → $101
Current: $91.98
Upside: +9.81%
Guardant Health
Feb 23, 2026
Reiterated: Buy
Price Target: $61 → $129
Current: $125.61
Upside: +2.70%
Myriad Genetics
Jan 13, 2026
Maintained: Buy
Price Target: $8
Current: $4.57
Upside: +75.05%
Azenta
Nov 25, 2025
Reiterated: Buy
Price Target: $35 → $45
Current: $22.69
Upside: +98.33%
Avantor
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $9.16
Upside: -
Revvity
Oct 28, 2025
Reiterated: Buy
Price Target: $115
Current: $98.37
Upside: +16.91%
Haemonetics
Aug 11, 2025
Downgraded: Buy
Price Target: $105 → $78
Current: $71.28
Upside: +9.43%
QuidelOrtho
Aug 6, 2025
Maintained: Buy
Price Target: $60 → $55
Current: $14.33
Upside: +283.81%
Fulgent Genetics
Aug 4, 2025
Reiterated: Buy
Price Target: $25
Current: $19.15
Upside: +30.55%
Thermo Fisher Scientific
Jul 24, 2025
Maintained: Buy
Price Target: $525 → $535
Current: $472.80
Upside: +13.16%
Jul 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $184.30
Upside: -
Mar 28, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $223.97
Upside: n/a
Feb 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.90
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $85 → $175
Current: $215.31
Upside: n/a
May 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $22.25
Upside: n/a
Jul 18, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $4.09
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: n/a
Current: $48.73
Upside: n/a
Feb 15, 2023
Maintained: Hold
Price Target: n/a
Current: $4.04
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1,050
Current: $0.0001
Upside: n/a
Feb 11, 2021
Reiterated: Hold
Price Target: n/a
Current: $22.00
Upside: n/a
Feb 2, 2021
Reiterated: Hold
Price Target: n/a
Current: $562.16
Upside: n/a